FGF21 has been reported to normalize glucose and lipid homeostasis, thus preventing the development of metabolic disorders, such as obesity and diabetes (So et al., 2015; So and Leung 2016). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.